Ocular Therapeutix (OCUL) Misses Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts OCUL Hot Sheet
Join SI Premium – FREE
Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.38), $0.09 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $17.07 million.
For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
- Argan (AGX) Tops Q2 EPS by 110c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
